Palisade Bio PALI
NASDAQ PALI
$1.17 +0.04 (+3.54%)
At close: Nov 11, 2026 · 4:00 PM EST

Palisade Bio (PALI) Price to Earnings (2009 - 2022)

Updated

Palisade Bio's Price to Earnings was 94.20 in Q2 2022.

Analysis

Palisade Bio (PALI) Price to Earnings (2009 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Palisade Bio 239.59 Mn -265.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 94.20
Dec 31, 2009 0.00
Sep 30, 2009 0.00
Jun 30, 2009 0.00
API Access

Palisade Bio Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PALI&period=max&api_key=YOUR_API_KEY